Life Engine Animal Health or LEAH Labs, led by CEO and co-founder Wes Wierson, uses non-viral CAR T cell cancer therapy to try to create a better treatment for B cell lymphoma cancer in dogs. That type of cancer is comparable to Non-Hodgkin's lymphoma in humans. The Rochester-based firm recently proved the treatment was safe to use in dogs and now plans to conduct a pilot study later this year.
Beyond the Skyline is a podcast about economic development, commercial real estate and construction in Minnesota. Above all, it’s a show about what’s next, creativity and the innovation in technology that are changing how we work and shaping the future of business throughout our state.
Elevating and expanding diversity, equality and inclusion (DE&I) efforts is gaining prominence for many organizations, including those in Minnesota’s Medical Alley.
Medical Alley companies are not only undertaking internal DE&I reflection and initiatives, but they’re also looking externally to help their communities achieve better equities in health. To ensure this DE&I work is successful and meaningful, Alexis Kochanski, of the Medical Alley Association, says employees at all levels must buy in to the work.
Q&A: Medical Alley Association promotes diversity buy-in finance-commerce.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finance-commerce.com Daily Mail and Mail on Sunday newspapers.
That included a mix of private and public capital, according to the Golden Valley-based Medical Alley Association.
Cash continues to flow into Minnesota’s medical startups. On Monday, the Medical Alley Association reported that its member companies raised more than $347 million during 2021’s first quarter.
That figure includes $109 million in private capital and $238 million through public markets, the med-tech trade group said in a news release. Investments in the first quarter are paving the way for “another record-breaking year” for Medical Alley, the group said.
“While 2020 was characterized by large, later-stage raises, 2021 is starting out with a refilling of the early-stage pipeline,” Medical Alley officials said in the release. “A total of 43 companies raised funds, nearly doubling Q1 2020’s total of 22.”
Pharmaceutical Ingredients Manufacturer Nu-Tek BioSciences Announces Plans To Build New Facility In Minnesota
Nu-Tek BioSciences, an innovative manufacturer of industrial ingredients used in the development and manufacturing of pharmaceuticals, will build a new manufacturing facility in Austin, Minnesota.
The project will be the first dedicated, animal-free peptone, and protein hydrolysate manufacturing facility in the U.S. This U.S. owned peptone manufacturing plant will help meet the rapidly growing demand for materials used to manufacture biologics.
Nu-Tek is currently supplying a critical component used in the manufacture of a COVID-19 vaccine. According to company officials, this investment into manufacturing comes at a time when pharmaceutical companies are seeking solutions to mitigate supply chain risk. With the current pressures of COVID-19 vaccine manufacturing, this capacity will solidify the Company’s commitment to building businesses and assets with long-term sustai